GL1X · GenesisL1 explorer

MolNFT v1 · #161467 · protein

Crystal structure of human kallikrein 6 (I218Y) in complex with GSK144

6QFG · Kallikrein-6: “Crystal structure of human kallikrein 6 (I218Y) in complex with GSK144”. X-ray diffraction, 1 ligand (J08), 3 pockets (best druggability 0.71). MolNFT v1 #161467 on GenesisL1: 3D structure, binding sites and pockets…

PDB
6QFG
Type
protein
Length
445 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Kallikrein-6
EC
3.4.21.-
UniProt
Q92876
Ligands
J08
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AKallikrein-6 (EC 3.4.21.-)protein22310% helix, 38% strandQ92876
BKallikrein-6 (EC 3.4.21.-)protein22210% helix, 38% strandQ92876

Ligands and binding sites

  • J08 · 4-[(5-phenyl-1~{H}-imidazol-2-yl)methylamino]-2-(pyridin-3-ylmethoxy)benzenecarboximidamide · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16740.710.7869J08
21020.470.8031empty
3530.340.7816empty

Interfaces

1 interface between chains.

  • A–B · 543 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 disulfide (disulfide).

Compared structures

  • 6QFG · Crystal Structure of Human Kallikrein 6 (I218Y) in complex with GSK144 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q92876 · AlphaFold monomer V2.0 prediction for kallikrein-6 (Q92876) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.